JPM vs NXG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NXG exhibits severe financial fragility, highlighted by a critical Piotroski F-Score of 1/9, indicating poor operational health. The stock is currently trading at $57.29, a significant premium over its growth-based intrinsic value of $39.76. Furthermore, the dividend is unsustainable with a payout ratio of 112.24%, signaling a high risk of a dividend cut. Despite strong historical price appreciation, the current technical trend is heavily bearish (10/100), suggesting a potential reversal from its 52-week highs.
Compare Another Pair
Related Comparisons
JPM vs NXG: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and NXG NextGen Infrastructure Income Fund (NXG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.